apraize
ABOUT APRAIZE
Apraize is a brand name for the generic medicine Apremilast (20mg). Apremilast is used to treat certain types of inflammatory conditions such as psoriatic arthritis and plaque psoriasis. These conditions are characterized by inflammation and overactive immune responses, leading to symptoms like joint pain, swelling, and skin lesions. Apremilast is a phosphodiesterase 4 (PDE4) inhibitor which works by reducing the activity of the immune system, thereby decreasing inflammation and alleviating symptoms.
Apraize is available in the strength of 20mg in tablet form. It is produced in India by Ipca Laboratories Ltd, a reputable pharmaceutical company known for its commitment to quality and innovation in healthcare. Ipca Laboratories Ltd meets WHO Good Manufacturing Practice (GMP) certification criteria according to CDSCO, ensuring that Apraize is manufactured under stringent quality standards.
Alternatives to Apraize include other brands containing the same active ingredient, Apremilast, such as Otezla and Sovaldi. These alternatives may vary in terms of price, availability, and formulation, but they offer similar therapeutic benefits for managing inflammatory conditions.
INTRODUCTION OF APRAIZE
Apraize is a revolutionary medication designed to manage and treat chronic inflammatory conditions like psoriatic arthritis and plaque psoriasis. These conditions are often debilitating, affecting the quality of life of individuals by causing persistent pain, discomfort, and visible skin lesions. Apraize, with its active ingredient Apremilast, offers a targeted approach to managing these symptoms by modulating the immune system's response and reducing inflammation.
Psoriatic arthritis is a form of arthritis that affects some people who have psoriasis, a condition that features red patches of skin topped with silvery scales. Apraize helps in alleviating the joint pain and swelling associated with this condition, thereby improving joint function and mobility. Similarly, in plaque psoriasis, Apraize aids in reducing the severity of skin lesions, leading to clearer skin and enhanced self-esteem for patients.
What sets Apraize apart is its mechanism of action as a PDE4 inhibitor. By inhibiting the PDE4 enzyme, Apraize reduces the production of inflammatory mediators in the body, leading to a decrease in inflammation and an improvement in symptoms. This makes Apraize a valuable option for patients seeking relief from the chronic and often painful symptoms of psoriatic arthritis and plaque psoriasis. With its proven efficacy and safety profile, Apraize is a trusted choice for healthcare providers and patients alike.
CONDITIONS TREATED BY APRAIZE
Apraize is primarily used to manage and treat psoriatic arthritis and plaque psoriasis. These conditions are characterized by chronic inflammation and immune system dysregulation, leading to symptoms such as joint pain, swelling, and skin lesions. By targeting the underlying inflammatory processes, Apraize helps in reducing these symptoms and improving the quality of life for patients.
MOLECULE NAME
Apremilast (20mg)
HOW IT WORKS APRAIZE
Apraize works by inhibiting the enzyme phosphodiesterase 4 (PDE4), which plays a key role in the inflammatory process. By blocking PDE4, Apraize reduces the production of pro-inflammatory cytokines and increases the production of anti-inflammatory cytokines. This dual action helps in decreasing inflammation and alleviating symptoms associated with psoriatic arthritis and plaque psoriasis.
COMMON SIDE EFFECTS OF APRAIZE
Common side effects of Apraize may include diarrhea, nausea, headache, and upper respiratory tract infections. These side effects are generally mild and tend to resolve with continued use of the medication. However, patients are advised to consult their healthcare provider if they experience any persistent or severe side effects.
HOW TO TAKE APRAIZE
Apraize should be taken as prescribed by a healthcare provider. It is typically administered orally in tablet form, with or without food. Patients are advised to follow the dosage instructions carefully and not to exceed the recommended dose. Consistency in taking the medication at the same time each day can help in achieving optimal therapeutic outcomes.
PRECAUTIONS OF APRAIZE
Before starting Apraize, patients should inform their healthcare provider about any existing medical conditions, allergies, or medications they are currently taking. Apraize may not be suitable for individuals with a history of depression or suicidal thoughts. Regular monitoring by a healthcare provider is recommended to ensure the safe and effective use of the medication.
FOOD & DRUG INTERACTIONS OF APRAIZE
Patients taking Apraize should avoid consuming grapefruit or grapefruit juice, as it may interfere with the metabolism of the medication. Additionally, Apraize may interact with other medications, such as rifampin and phenytoin, potentially affecting its efficacy. It is important to discuss all medications and supplements with a healthcare provider to avoid potential interactions.
ALTERNATIVE BRANDS OF APRAIZE
Alternative brands to Apraize include Otezla and Sovaldi, which also contain the active ingredient Apremilast. These alternatives may offer similar therapeutic benefits and can be considered in consultation with a healthcare provider based on individual patient needs and preferences.
FACT MEDICINE OF APRAIZE
Apraize is a PDE4 inhibitor used to treat psoriatic arthritis and plaque psoriasis. It helps reduce inflammation and alleviate symptoms by modulating the immune response. Manufactured by Ipca Laboratories Ltd, Apraize is available in 20mg tablet form and is known for its efficacy and safety in managing chronic inflammatory conditions.

More medicines by Ipca Laboratories Ltd
Related Medicine
Available in 3 variations

Apraize 30mg Tablet
strip of 10 tablets

Apraize 10 Tablet
strip of 4 tablets

Apraize 20mg Tablet
strip of 4 tablets
Related Faqs

How long does it take for Apraize 20 Tablet to work?
Apraize 20 Tablet is used to treat plaque psoriasis (red, scaly, thick, itchy, painful patches on skin) and psoriatic arthritis (a condition that causes joint pain and swelling). It is a long-term treatment and may take about 16 weeks to show an improvement.

Is Apxenta 10 Tablet an immunosuppressant?
No, Apxenta 10 Tablet is not an immunosuppressant. It belongs to a class of medicines known as phosphodiesterase 4 inhibitors (PDE4) which work by blocking the activity of PDE4. PDE4 is found in inflammatory cells and blocking it helps in reducing the molecules responsible for inflammation.
Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.
apraize
Prescription Required
Manufacturer :
Ipca Laboratories LtdComposition :
apremilast